MAYNE PHARMA GROUP LIMITED - Announcements

1.77%

$4.99

Market Cap $405.4M

Healthcare Drug Manufacturers - Specialty & Generic

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

FIREBRICK PHARMA

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

MYX	2018 Full Year Results Investor Presentation	PRICE SENSITIVE	24/08/18	1.43MB	Share
MYX	2018 Full Year Results Media Release	PRICE SENSITIVE	24/08/18	444.47KB	Share
MYX	Full Year Statutory Accounts	PRICE SENSITIVE	24/08/18	7.43MB	Share
MYX	Mayne Pharma acquires generic Efudex in the US	PRICE SENSITIVE	23/07/18	269.46KB	Share
MYX	SUBA-Itraconazole NDA accepted for review by US FDA	PRICE SENSITIVE	02/05/18	390.44KB	Share
MYX	Mayne Pharma opens new US manufacturing facility	PRICE SENSITIVE	18/04/18	267.75KB	Share
MYX	Mayne Pharma launches Amiodarone 200mg tablets in the US	PRICE SENSITIVE	17/04/18	256.29KB	Share
MYX	Mayne Pharma's generic NuvaRing accepted for filing by FDA	PRICE SENSITIVE	20/03/18	391.96KB	Share
MYX	Mayne Pharma launches doxycycline IR capsules in the US	PRICE SENSITIVE	16/03/18	383.19KB	Share
MYX	First generic launch of Ritalin LA 10mg capsules in the US	PRICE SENSITIVE	01/03/18	98.7KB	Share
MYX	2018 Half Year Investor Presentation	PRICE SENSITIVE	23/02/18	1.74MB	Share
MYX	2018 Half Year Media Release	PRICE SENSITIVE	23/02/18	437.47KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/18	1.4MB	Share
MYX	2017 CEO's Speech	PRICE SENSITIVE	28/11/17	297.96KB	Share
MYX	Mayne Pharma launches clozapine tablets in the US	PRICE SENSITIVE	09/11/17	247.68KB	Share
MYX	Mayne Pharma adds two products to its Australian portfolio	PRICE SENSITIVE	15/09/17	427.72KB	Share
MYX	Preliminary Final Report	PRICE SENSITIVE	25/08/17	1.5MB	Share
MYX	Mayne Pharma market update	PRICE SENSITIVE	08/08/17	447.89KB	Share
MYX	FDA approval and first generic launch of Acticlate tablets	PRICE SENSITIVE	15/06/17	96.5KB	Share
MYX	Response to ASX Aware Letter	PRICE SENSITIVE	04/05/17	653.95KB	Share
MYX	Clarification statement	PRICE SENSITIVE	02/05/17	89.14KB	Share
MYX	Mayne Pharma acquires rights to generic Duragesic in the US	PRICE SENSITIVE	09/03/17	268.96KB	Share
MYX	License and supply agreement for generic Nuvaring in the US	PRICE SENSITIVE	28/02/17	103.27KB	Share
MYX	2017 Half Year Media Release	PRICE SENSITIVE	24/02/17	312.52KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/17	1.35MB	Share
MYX	Mayne Pharma launches Butalbital / APAP tablets in the US	PRICE SENSITIVE	16/02/17	246.53KB	Share
MYX	Mayne Pharma launches Amiodarone 100mg tablets	PRICE SENSITIVE	13/01/17	95.19KB	Share
MYX	Mayne Pharma launches Fabior and Sorilux in the US	PRICE SENSITIVE	11/01/17	271.31KB	Share
MYX	Update on Status of DOJ Investigation	PRICE SENSITIVE	16/12/16	229.2KB	Share
MYX	Update on Status of DOJ Investigation	PRICE SENSITIVE	04/11/16	98.15KB	Share
MYX	MYX launches generic MS Contin (morphine sulfate) tablets-MYX.AX	PRICE SENSITIVE	03/11/16	108.48KB	Share
MYX	MYX launches generic MS Contin (morphine sulfate) tablets	PRICE SENSITIVE	03/11/16	108.48KB	Share
MYX	1st generic proprietary product shipped to US, temozolomide,MYX-IDT.AX	PRICE SENSITIVE	02/11/16	128.48KB	Share
MYX	MYX launches generic Entocort EC (Budesonide) capsules-MYX.AX	PRICE SENSITIVE	27/10/16	101.92KB	Share
MYX	Appendix 4E, Directors Report and Financial Statements-MYX.AX	PRICE SENSITIVE	28/08/16	1.58MB	Share
MYX	Appendix 4E, Directors Report and Financial Statements-MYX.AX	PRICE SENSITIVE	26/08/16	1.58MB	Share
MYX	MYX announces acquisition of US foam dermatology assets-MYX.AX	PRICE SENSITIVE	18/08/16	140.14KB	Share
MYX	MYX announces settlement from patent infringement case-MYX.AX	PRICE SENSITIVE	29/07/16	97.53KB	Share
MYX	Completion institutional entitlement offer and placement-MYX.AX	PRICE SENSITIVE	30/06/16	282.55KB	Share
MYX	MYX announces acquisition of US generic product portfolio-MYX.AX	PRICE SENSITIVE	28/06/16	189.33KB	Share
MYX	Trading Halt-MYX.AX	PRICE SENSITIVE	28/06/16	461.51KB	Share
MYX	MYX receives first generic approval of Tikosyn capsules-MYX.AX	PRICE SENSITIVE	07/06/16	203.54KB	Share
MYX	Mayne Pharma receives FDA approval for Doryx MPC tablets-MYX.AX	PRICE SENSITIVE	23/05/16	161.16KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/16	1.02MB	Share
MYX	2015 Appendix 4E & Annual Report	PRICE SENSITIVE	28/08/15	4.5MB	Share
MYX	Mayne announces strategic investment in US facilities	PRICE SENSITIVE	28/08/15	252.01KB	Share
MYX	Mayne Pharma recipient of A$4m Government Grant	PRICE SENSITIVE	04/08/15	232.74KB	Share
MYX	Mayne Pharma successfully completes US$125m debt financing	PRICE SENSITIVE	25/06/15	209.94KB	Share
MYX	New equity investment in Hedgepath Pharmaceuticals	PRICE SENSITIVE	18/05/15	131.45KB	Share
MYX	US Oxycodone franchise restructure and Doryx re-launch	PRICE SENSITIVE	04/05/15	244.02KB	Share
MYX	Half Year Results and Accounts	PRICE SENSITIVE	26/02/15	912.55KB	Share
MYX	Pfizer withdraws US Tikosyn Litigation against Mayne Pharma	PRICE SENSITIVE	25/02/15	320.25KB	Share
MYX	Completion institutional entitlement offer and placement	PRICE SENSITIVE	12/02/15	424.05KB	Share
MYX	Mayne Pharma announces acquisition of Doryx	PRICE SENSITIVE	10/02/15	311.83KB	Share
MYX	Trading Halt	PRICE SENSITIVE	10/02/15	427.1KB	Share
MYX	Mayne Pharma announces US Paragraph IV Challenge	PRICE SENSITIVE	18/11/14	243.9KB	Share
MYX	2014 Appendix 4E & Annual Report	PRICE SENSITIVE	27/08/14	2.8MB	Share
MYX	Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals	PRICE SENSITIVE	25/06/14	133.3KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/14	929.67KB	Share
MYX	Completion of placement	PRICE SENSITIVE	13/02/14	108.63KB	Share
MYX	Mayne Pharma announces acquisition of LORCET & ESGIC	PRICE SENSITIVE	12/02/14	249.77KB	Share
MYX	Trading Halt	PRICE SENSITIVE	12/02/14	373.4KB	Share
MYX	Mayne Pharma results and product update	PRICE SENSITIVE	06/02/14	220.42KB	Share
MYX	MYX announces US agreement for Itraconazole in Cancer	PRICE SENSITIVE	11/09/13	325.88KB	Share
MYX	2013 Full Year Results Appendix 4E	PRICE SENSITIVE	27/08/13	974.61KB	Share
MYX	Mayne Pharma Signs European SUBACAP Distribution Agreements	PRICE SENSITIVE	09/08/13	152.52KB	Share
MYX	Mayne Pharma Launches Generic Doryx	PRICE SENSITIVE	09/07/13	211.63KB	Share
MYX	Mayne Pharma announces acquisition of Libertas	PRICE SENSITIVE	02/07/13	254.47KB	Share
MYX	FDA Approval of New 200mg Doryx Tablet	PRICE SENSITIVE	12/04/13	453.17KB	Share
MYX	2013 Half Year Media Release	PRICE SENSITIVE	27/02/13	280.93KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/13	670.86KB	Share
MYX	Completion of placement	PRICE SENSITIVE	17/12/12	89.52KB	Share
MYX	Mayne Pharma announces the acquisition of Kapanol	PRICE SENSITIVE	14/12/12	93.33KB	Share
MYX	Trading Halt	PRICE SENSITIVE	14/12/12	77.16KB	Share
MYX	2012 AGM CEO's Speech	PRICE SENSITIVE	09/11/12	148.95KB	Share
MYX	Mayne Pharma announces in-licensing agreement	PRICE SENSITIVE	01/11/12	66.25KB	Share
MYX	Retail Offer Booklet	PRICE SENSITIVE	12/10/12	3.32MB	Share
MYX	Completion institutional entitlement/unconditional placement	PRICE SENSITIVE	08/10/12	176.46KB	Share
MYX	Mayne Pharma Announces the Acquisition of Metrics, Inc.	PRICE SENSITIVE	04/10/12	238.35KB	Share
MYX	Trading Halt	PRICE SENSITIVE	04/10/12	204.84KB	Share
MYX	Media Speculation	PRICE SENSITIVE	24/09/12	97KB	Share
MYX	Media Speculation	PRICE SENSITIVE	24/09/12	97KB	Share
MYX	Preliminary Final Report	PRICE SENSITIVE	21/08/12	388.04KB	Share
MYX	Mayne Pharma announces SUBACAP approvable	PRICE SENSITIVE	21/06/12	134.73KB	Share
MYX	US Court decides on Doryx 161 Patent	PRICE SENSITIVE	01/05/12	131.61KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/12	1.13MB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	10/02/12	69.85KB	Share
MYX	SUBACAP Update	PRICE SENSITIVE	15/12/11	81.25KB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	13/12/11	86.03KB	Share
MYX	MYX APPOINTS SCOTT RICHARDS AS CEO	PRICE SENSITIVE	02/12/11	492.25KB	Share
MYX	Chairman's Address to Shareholders	PRICE SENSITIVE	23/11/11	25.83KB	Share
MYX	Doryx Generic Update	PRICE SENSITIVE	22/09/11	472.19KB	Share
MYX	FDA Approval Of New Dual-Scored 150mg Doryx Tablet	PRICE SENSITIVE	14/09/11	478.46KB	Share
MYX	Preliminary Final Report	PRICE SENSITIVE	31/08/11	393.08KB	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	05/07/11	479.25KB	Share
MYX	Mayne Pharma Market Update	PRICE SENSITIVE	15/06/11	79.84KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/11	632.5KB	Share
MYX	Future Cash Flow Reporting	PRICE SENSITIVE	01/02/11	65.04KB	Share
MYX	Mayna Pharma Files SUBACAP for Registration in the EU	PRICE SENSITIVE	17/12/10	94KB	Share

MYX 2018 Full Year Results Investor Presentation
24/08/18	PRICE SENSITIVE	1.43MB	Share
MYX 2018 Full Year Results Media Release
24/08/18	PRICE SENSITIVE	444.47KB	Share
MYX Full Year Statutory Accounts
24/08/18	PRICE SENSITIVE	7.43MB	Share
MYX Mayne Pharma acquires generic Efudex in the US
23/07/18	PRICE SENSITIVE	269.46KB	Share
MYX SUBA-Itraconazole NDA accepted for review by US FDA
02/05/18	PRICE SENSITIVE	390.44KB	Share
MYX Mayne Pharma opens new US manufacturing facility
18/04/18	PRICE SENSITIVE	267.75KB	Share
MYX Mayne Pharma launches Amiodarone 200mg tablets in the US
17/04/18	PRICE SENSITIVE	256.29KB	Share
MYX Mayne Pharma's generic NuvaRing accepted for filing by FDA
20/03/18	PRICE SENSITIVE	391.96KB	Share
MYX Mayne Pharma launches doxycycline IR capsules in the US
16/03/18	PRICE SENSITIVE	383.19KB	Share
MYX First generic launch of Ritalin LA 10mg capsules in the US
01/03/18	PRICE SENSITIVE	98.7KB	Share
MYX 2018 Half Year Investor Presentation
23/02/18	PRICE SENSITIVE	1.74MB	Share
MYX 2018 Half Year Media Release
23/02/18	PRICE SENSITIVE	437.47KB	Share
MYX Half Yearly Report and Accounts
23/02/18	PRICE SENSITIVE	1.4MB	Share
MYX 2017 CEO's Speech
28/11/17	PRICE SENSITIVE	297.96KB	Share
MYX Mayne Pharma launches clozapine tablets in the US
09/11/17	PRICE SENSITIVE	247.68KB	Share
MYX Mayne Pharma adds two products to its Australian portfolio
15/09/17	PRICE SENSITIVE	427.72KB	Share
MYX Preliminary Final Report
25/08/17	PRICE SENSITIVE	1.5MB	Share
MYX Mayne Pharma market update
08/08/17	PRICE SENSITIVE	447.89KB	Share
MYX FDA approval and first generic launch of Acticlate tablets
15/06/17	PRICE SENSITIVE	96.5KB	Share
MYX Response to ASX Aware Letter
04/05/17	PRICE SENSITIVE	653.95KB	Share
MYX Clarification statement
02/05/17	PRICE SENSITIVE	89.14KB	Share
MYX Mayne Pharma acquires rights to generic Duragesic in the US
09/03/17	PRICE SENSITIVE	268.96KB	Share
MYX License and supply agreement for generic Nuvaring in the US
28/02/17	PRICE SENSITIVE	103.27KB	Share
MYX 2017 Half Year Media Release
24/02/17	PRICE SENSITIVE	312.52KB	Share
MYX Half Yearly Report and Accounts
24/02/17	PRICE SENSITIVE	1.35MB	Share
MYX Mayne Pharma launches Butalbital / APAP tablets in the US
16/02/17	PRICE SENSITIVE	246.53KB	Share
MYX Mayne Pharma launches Amiodarone 100mg tablets
13/01/17	PRICE SENSITIVE	95.19KB	Share
MYX Mayne Pharma launches Fabior and Sorilux in the US
11/01/17	PRICE SENSITIVE	271.31KB	Share
MYX Update on Status of DOJ Investigation
16/12/16	PRICE SENSITIVE	229.2KB	Share
MYX Update on Status of DOJ Investigation
04/11/16	PRICE SENSITIVE	98.15KB	Share
MYX MYX launches generic MS Contin (morphine sulfate) tablets-MYX.AX
03/11/16	PRICE SENSITIVE	108.48KB	Share
MYX MYX launches generic MS Contin (morphine sulfate) tablets
03/11/16	PRICE SENSITIVE	108.48KB	Share
MYX 1st generic proprietary product shipped to US, temozolomide,MYX-IDT.AX
02/11/16	PRICE SENSITIVE	128.48KB	Share
MYX MYX launches generic Entocort EC (Budesonide) capsules-MYX.AX
27/10/16	PRICE SENSITIVE	101.92KB	Share
MYX Appendix 4E, Directors Report and Financial Statements-MYX.AX
28/08/16	PRICE SENSITIVE	1.58MB	Share
MYX Appendix 4E, Directors Report and Financial Statements-MYX.AX
26/08/16	PRICE SENSITIVE	1.58MB	Share
MYX MYX announces acquisition of US foam dermatology assets-MYX.AX
18/08/16	PRICE SENSITIVE	140.14KB	Share
MYX MYX announces settlement from patent infringement case-MYX.AX
29/07/16	PRICE SENSITIVE	97.53KB	Share
MYX Completion institutional entitlement offer and placement-MYX.AX
30/06/16	PRICE SENSITIVE	282.55KB	Share
MYX MYX announces acquisition of US generic product portfolio-MYX.AX
28/06/16	PRICE SENSITIVE	189.33KB	Share
MYX Trading Halt-MYX.AX
28/06/16	PRICE SENSITIVE	461.51KB	Share
MYX MYX receives first generic approval of Tikosyn capsules-MYX.AX
07/06/16	PRICE SENSITIVE	203.54KB	Share
MYX Mayne Pharma receives FDA approval for Doryx MPC tablets-MYX.AX
23/05/16	PRICE SENSITIVE	161.16KB	Share
MYX Half Yearly Report and Accounts
26/02/16	PRICE SENSITIVE	1.02MB	Share
MYX 2015 Appendix 4E & Annual Report
28/08/15	PRICE SENSITIVE	4.5MB	Share
MYX Mayne announces strategic investment in US facilities
28/08/15	PRICE SENSITIVE	252.01KB	Share
MYX Mayne Pharma recipient of A$4m Government Grant
04/08/15	PRICE SENSITIVE	232.74KB	Share
MYX Mayne Pharma successfully completes US$125m debt financing
25/06/15	PRICE SENSITIVE	209.94KB	Share
MYX New equity investment in Hedgepath Pharmaceuticals
18/05/15	PRICE SENSITIVE	131.45KB	Share
MYX US Oxycodone franchise restructure and Doryx re-launch
04/05/15	PRICE SENSITIVE	244.02KB	Share
MYX Half Year Results and Accounts
26/02/15	PRICE SENSITIVE	912.55KB	Share
MYX Pfizer withdraws US Tikosyn Litigation against Mayne Pharma
25/02/15	PRICE SENSITIVE	320.25KB	Share
MYX Completion institutional entitlement offer and placement
12/02/15	PRICE SENSITIVE	424.05KB	Share
MYX Mayne Pharma announces acquisition of Doryx
10/02/15	PRICE SENSITIVE	311.83KB	Share
MYX Trading Halt
10/02/15	PRICE SENSITIVE	427.1KB	Share
MYX Mayne Pharma announces US Paragraph IV Challenge
18/11/14	PRICE SENSITIVE	243.9KB	Share
MYX 2014 Appendix 4E & Annual Report
27/08/14	PRICE SENSITIVE	2.8MB	Share
MYX Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals
25/06/14	PRICE SENSITIVE	133.3KB	Share
MYXHalf Yearly Report and Accounts
26/02/14	PRICE SENSITIVE	929.67KB	Share
MYXCompletion of placement
13/02/14	PRICE SENSITIVE	108.63KB	Share
MYXMayne Pharma announces acquisition of LORCET & ESGIC
12/02/14	PRICE SENSITIVE	249.77KB	Share
MYXTrading Halt
12/02/14	PRICE SENSITIVE	373.4KB	Share
MYXMayne Pharma results and product update
06/02/14	PRICE SENSITIVE	220.42KB	Share
MYXMYX announces US agreement for Itraconazole in Cancer
11/09/13	PRICE SENSITIVE	325.88KB	Share
MYX2013 Full Year Results Appendix 4E
27/08/13	PRICE SENSITIVE	974.61KB	Share
MYXMayne Pharma Signs European SUBACAP Distribution Agreements
09/08/13	PRICE SENSITIVE	152.52KB	Share
MYXMayne Pharma Launches Generic Doryx
09/07/13	PRICE SENSITIVE	211.63KB	Share
MYXMayne Pharma announces acquisition of Libertas
02/07/13	PRICE SENSITIVE	254.47KB	Share
MYXFDA Approval of New 200mg Doryx Tablet
12/04/13	PRICE SENSITIVE	453.17KB	Share
MYX2013 Half Year Media Release
27/02/13	PRICE SENSITIVE	280.93KB	Share
MYXHalf Yearly Report and Accounts
27/02/13	PRICE SENSITIVE	670.86KB	Share
MYXCompletion of placement
17/12/12	PRICE SENSITIVE	89.52KB	Share
MYXMayne Pharma announces the acquisition of Kapanol
14/12/12	PRICE SENSITIVE	93.33KB	Share
MYXTrading Halt
14/12/12	PRICE SENSITIVE	77.16KB	Share
MYX2012 AGM CEO's Speech
09/11/12	PRICE SENSITIVE	148.95KB	Share
MYXMayne Pharma announces in-licensing agreement
01/11/12	PRICE SENSITIVE	66.25KB	Share
MYXRetail Offer Booklet
12/10/12	PRICE SENSITIVE	3.32MB	Share
MYXCompletion institutional entitlement/unconditional placement
08/10/12	PRICE SENSITIVE	176.46KB	Share
MYXMayne Pharma Announces the Acquisition of Metrics, Inc.
04/10/12	PRICE SENSITIVE	238.35KB	Share
MYXTrading Halt
04/10/12	PRICE SENSITIVE	204.84KB	Share
MYXMedia Speculation
24/09/12	PRICE SENSITIVE	97KB	Share
MYXMedia Speculation
24/09/12	PRICE SENSITIVE	97KB	Share
MYXPreliminary Final Report
21/08/12	PRICE SENSITIVE	388.04KB	Share
MYXMayne Pharma announces SUBACAP approvable
21/06/12	PRICE SENSITIVE	134.73KB	Share
MYXUS Court decides on Doryx 161 Patent
01/05/12	PRICE SENSITIVE	131.61KB	Share
MYXHalf Yearly Report and Accounts
28/02/12	PRICE SENSITIVE	1.13MB	Share
MYXDoryx Generic Update
10/02/12	PRICE SENSITIVE	69.85KB	Share
MYXSUBACAP Update
15/12/11	PRICE SENSITIVE	81.25KB	Share
MYXDoryx Generic Update
13/12/11	PRICE SENSITIVE	86.03KB	Share
MYXMYX APPOINTS SCOTT RICHARDS AS CEO
02/12/11	PRICE SENSITIVE	492.25KB	Share
MYXChairman's Address to Shareholders
23/11/11	PRICE SENSITIVE	25.83KB	Share
MYXDoryx Generic Update
22/09/11	PRICE SENSITIVE	472.19KB	Share
MYXFDA Approval Of New Dual-Scored 150mg Doryx Tablet
14/09/11	PRICE SENSITIVE	478.46KB	Share
MYXPreliminary Final Report
31/08/11	PRICE SENSITIVE	393.08KB	Share
MYXMayne Pharma Market Update
05/07/11	PRICE SENSITIVE	479.25KB	Share
MYXMayne Pharma Market Update
15/06/11	PRICE SENSITIVE	79.84KB	Share
MYXHalf Yearly Report and Accounts
25/02/11	PRICE SENSITIVE	632.5KB	Share
MYXFuture Cash Flow Reporting
01/02/11	PRICE SENSITIVE	65.04KB	Share
MYXMayna Pharma Files SUBACAP for Registration in the EU
17/12/10	PRICE SENSITIVE	94KB	Share

REFRESH

First

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.99		Change -0.090(1.77%)		Mkt cap ! $405.4M

Open	High	Low	Value	Volume
$5.05	$5.05	$4.99	$1.254M	250.3K

Buyers (Bids)

No.	Vol.	Price($)
4	22359	$4.98

Sellers (Offers)

Price($)	Vol.	No.
$5.08	2631	2

View Market Depth

No.	Vol.	Price($)
4	22359	4.980
2	15084	4.970
1	5000	4.960
4	5480	4.950
1	500	4.930

Price($)	Vol.	No.
5.080	2631	2
5.090	2000	1
5.100	25000	1
5.150	25000	1
5.170	5000	1

Last trade - 16.11pm 08/08/2025 (20 minute delay)

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories